The importance of good nutrition and food security among people living with HIV infection (PLHIV) is widely recognized. In resource-constrained settings, food insecurity is increasingly recognized as an important barrier to retention in care and adherence to antiretroviral therapy (ART). However, there are few studies demonstrating that food and nutrition assistance programs can improve HIV-related outcomes. This study will address this gap by comparing the effectiveness of three models for short-term support for PLHIV. Food insecure women and men on ART will be randomized into one of three groups: 1) nutrition assessment and counseling (NAC) alone, 2) NAC plus food assistance, or 3) NAC plus cash transfers. The investigators will compare the effect of the three approaches on ART adherence and retention in care after 6, 12, and 24-36 months of follow-up. The investigators hypothesize that NAC plus short-term support in the form of food or cash assistance will result in better adherence to ART and retention in care than NAC alone, and that the effects of NAC plus food assistance will be the same as NAC plus cash assistance. The results from the study will provide evidence about which assistance modalities for PLHIV work best to improve ART adherence and retention in care, and under what conditions. This study will be conducted in Shinyanga Region, Tanzania, where approximately 17 percent of households have poor or borderline food consumption and 7.4 percent of people are living with HIV infection.
The investigators will randomize 785 food insecure women and men who recently initiated ART (determined with the Household Hunger Scale1) into one of three groups: 1) NAC alone , 2) NAC plus food assistance, or 3) NAC plus cash transfers. Food assistance will be a standard food ration consisting of maize flour, groundnuts, and beans. The cash transfer will be the equivalent value as the food ration (approximately $13 USD/month). Participants will receive the monthly food ration or cash transfer for up to six months if they continue to receive monthly HIV care (the standard of care). The investigators will compare the effect of NAC and food or cash assistance to the effect of NAC alone on ART adherence and retention in care at 6, 12, and 24-36 months (Objective #1). The investigators will also compare the effectiveness of NAC plus food assistance and NAC plus cash transfers to determine if their effects are the same (Objective #2).
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
800
Kahama District Hospital
Shinyanga, Shinyanga, Tanzania
Kambarage Health Center
Shinyanga, Shinyanga, Tanzania
Kishapu Health Center
Shinyanga, Shinyanga, Tanzania
Shinyanga Regional Hospital
Shinyanga, Shinyanga, Tanzania
Change from baseline of Medication Possession Ratio (MPR) at 6 months and at 12 months
ART adherence will be measured with the medication possession ratio (MPR), the proportion of time an individual is in possession of \>1 ARV or prescription for ARV. MPR is computed as the number of days ARVs are prescribed or dispensed divided by the number of days in the interval, and has been shown to be associated with short-term virologic outcomes. We will determine the proportion of patients with MPR ≥95% in each of the study arms.
Time frame: Baseline, 6 months, 12 months
Change from baseline in Food Security at 6 months and 12 months
Food security will be measured with several validated scales: the Household Food Insecurity Access Scale (HFIAS), the Household Hunger Scale (HHS) and the Individual Dietary Diversity Scale (IDDS).
Time frame: Baseline, 6 months, 12 months
Change from baseline in Viral Suppression at 6 months and 12 months
viral load \<400 copies/mL
Time frame: Baseline, 6 months, 12 months
Change from baseline in ART adherence at 6 months, 12 months, and 24-36 months
Proportion of patients who report taking at least 95% of prescribed doses in the previous month time frame. This will be measured by self-report.
Time frame: Baseline, 6 months, 12 months, and 24-36 months
Change from baseline in Body Mass Index (BMI) at 6 months and 12 months
body weight in kilograms (kg) divided by height in meters squared
Time frame: Baseline, 6, and 12 months
Change from baseline in Weight at 6 months and 12 months
Time frame: Baseline, 6 months, 12 months
Change from baseline of Medication Possession Ratio (MPR) at 12-36 months
ART adherence will be measured with the medication possession ratio (MPR), the proportion of time an individual is in possession of \>1 ARV or prescription for ARV. MPR is computed as the number of days ARVs are prescribed or dispensed divided by the number of days in the interval, and has been shown to be associated with short-term virologic outcomes. We will determine the proportion of patients with MPR ≥95% in each arm.
Time frame: 12-36 months
Retention in Care at 12-36 months
Retention in care will be assessed by number of participants in each arm that are still still in care at 12-36 months
Time frame: 12-36 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.